Thesis (M. Med. (Dermatology)) -- University of Limpopo, 2025Background: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are a spectrum of a life threatening illness commonly caused by drugs. There is a paucity of studies on this condition in the country, and to the researcher’s knowledge, no study was ever conducted at Pietersburg Hospital, Limpopo Province.
Objectives: To describe the clinical characteristics, evaluate management outcomes and determine associations between demographic factors and clinical characteristics of disease severity and management outcomes of patients with SJS/TEN at Pietersburg Hospital.
Methods: The study was a comprehensive retrospective cross-sectional review of medical records of SJS/TEN patients, who were diagnosed by dermatologists, at Pietersburg Hospital from January 2018 to December 2022. Descriptive statistics and statistical tests were used to analyse the data.
Results: The sample consisted of 43 African patients, 34.9% were male and 65.1% female, with an average age of 39±23 years. Patients with co-morbidities such as HIV, hypertension, and epilepsy accounted for 34.9% of the participants. Antibiotics and antiretrovirals drug groups commonly caused the disease, each accounting for 19% of cases. Allopurinol (14.3%) was identified as the commonest culprit, followed by trimethoprim-sulfamethoxazole (9.3%). Most patients (37.2%) had more than 30% and a SCORTEN score of 2 (34.9%). Older age was significantly associated with diabetes mellitus (p=0.003), HIV (p=0.024) and hypertension (p<0.001). Some SCORTEN parameters were significantly associated with age, which was also significantly associated with sepsis, acute renal failure and hyperkalaemia (p<0.05). The mortality rate was 13.9%, with factors such as disease severity, correlating with increased risk.
Conclusion: This study provided a comprehensive review of the clinical characteristics and treatment outcomes of patients with SJS/TEN. The findings underscore the need for prompt diagnosis, identification of causative agents, and tailored therapeutic approaches to improve patient outcomes
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.